Related Experiment Video
Updated: Aug 11, 2026
10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Blimp-1; immunoglobulin secretion and the switch to plasma cells
1Department of Molecular Genetics and Cell Biology, University of Chicago, IL 60637, USA. rsciamma@uchicago.edu
Current Topics in Microbiology and Immunology
|February 17, 2006
Summary
The transcription factor Blimp-1 (B lymphocyte-induced maturation protein 1) is crucial for plasma cell development and antibody secretion. It regulates diverse genes impacting B cell maturation, homeostasis, and immunoglobulin production.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- The transcription factor Blimp-1 is essential for B cell differentiation into antibody-secreting plasma cells.
- Blimp-1 controls a significant portion of the gene expression profile characteristic of plasma cells.
Purpose of the Study:
- To investigate the comprehensive gene regulatory network governed by Blimp-1 during plasma cell maturation.
- To elucidate how Blimp-1 influences various aspects of B cell differentiation, including migration, adhesion, and antibody secretion.
Main Methods:
- Microarray analysis to identify genes regulated by Blimp-1.
- Analysis of gene expression patterns in B cells during differentiation.
- Investigation of Blimp-1's role in mRNA processing and protein trafficking.
Main Results:
- Blimp-1 regulates a broad spectrum of genes involved in plasma cell maturation, affecting migration, adhesion, and homeostasis.
- Blimp-1 impacts immunoglobulin secretion through modulation of mRNA processing and endoplasmic reticulum activity.
- Blimp-1's regulatory functions are modulated by the B cell activation state, potentially via distinct functional domains.
Conclusions:
- Blimp-1 orchestrates a complex genetic program essential for generating plasma cells and ensuring effective humoral immunity.
- Distinct regions of Blimp-1 contribute to its multifaceted regulatory roles in B cell differentiation.
- Understanding Blimp-1's regulation provides insights into the development of adaptive immunity.
Related Concept Videos
01:24B Cell Activation and Differentiation
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:31Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
01:36Humoral Immune Responses
Overview